🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

RecruitingNAAges 65 Years - 75 YearsAllCairo University
NCT07193485 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Eustachian Tube Dysfunction (chronic obstructive form) * unilateral ear affetion * senior patients * chronci affection more than 3 months Exclusion Criteria: * obesity * cardiac probelms repsiratory problems
💊

What it tests

  • Buteyko breathing
  • usual care
📍

Where

1 site
Cairo University
Dokki, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy